Metronidazole Sg-Pharm (Metronidazole)

The drug is taken up by anaerobic bacteria and protozoa and undergoes intracellular reduction of its nitro group. This creates reactive nitro radicals that damage DNA and inhibit nucleic acid synthesis, ultimately leading to cell death while sparing most aerobic cells.

The specific dose and treatment duration are determined by the prescribing healthcare professional based on the infection type, severity, patient age, weight, and renal or hepatic function. Patients should follow the prescriber’s instructions and the product labeling precisely.

Metronidazole is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It may be used during pregnancy only if the potential benefit outweighs any risk. Small amounts are excreted in breast milk; breastfeeding decisions should be made with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Metronidazole is the most widely used nitroimidazole, offering a broad spectrum against anaerobic bacteria and protozoa. Compared with alternatives such as tinidazole, it has a similar efficacy profile but a shorter half‑life, which may require more frequent dosing. Choice of agent depends on infection type, patient tolerance, and local resistance patterns.

Metronidazole Sg-Pharm tablets should be stored at temperatures below 25 °C, in the original container, protected from moisture and direct sunlight. Keeping the product in a dry, cool place helps maintain potency throughout its shelf life.

The medication is supplied as oral tablets and is taken by mouth with or without food, as directed by a healthcare professional. Swallow the tablet whole with water; do not crush or chew unless specifically instructed. Full course completion is essential for optimal therapeutic outcome.

Serious adverse events, though rare, include seizures, peripheral neuropathy, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Patients should seek immediate medical attention if they experience neurological symptoms, rash, or signs of an allergic response while on therapy.

Metronidazole is contraindicated in individuals with a known hypersensitivity to metronidazole or other nitroimidazole derivatives. It should also be avoided in patients with severe hepatic impairment or in those who are actively consuming alcohol due to the risk of a disulfiram‑like reaction.